Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | S-1 | tm2035121-9_s1.htm | S-1 | 3352685 |
2 | EXHIBIT 3.1 | tm2035121d10_ex3-1.htm | EX-3.1 | 567127 |
3 | EXHIBIT 3.2 | tm2035121d10_ex3-2.htm | EX-3.2 | 657657 |
4 | EXHIBIT 10.1 | tm2035121d10_ex10-1.htm | EX-10.1 | 252372 |
5 | EXHIBIT 10.3 | tm2035121d10_ex10-3.htm | EX-10.3 | 336946 |
6 | EXHIBIT 10.4 | tm2035121d10_ex10-4.htm | EX-10.4 | 229847 |
7 | EXHIBIT 10.5 | tm2035121d10_ex10-5.htm | EX-10.5 | 576197 |
8 | EXHIBIT 10.6 | tm2035121d10_ex10-6.htm | EX-10.6 | 100752 |
9 | EXHIBIT 10.7 | tm2035121d10_ex10-7.htm | EX-10.7 | 104812 |
10 | EXHIBIT 10.8 | tm2035121d10_ex10-8.htm | EX-10.8 | 594045 |
11 | EXHIBIT 10.9 | tm2035121d10_ex10-9.htm | EX-10.9 | 13283 |
12 | EXHIBIT 10.10 | tm2035121d10_ex10-10.htm | EX-10.10 | 86292 |
13 | EXHIBIT 10.12 | tm2035121d10_ex10-12.htm | EX-10.12 | 82766 |
14 | EXHIBIT 10.13 | tm2035121d10_ex10-13.htm | EX-10.13 | 81276 |
15 | EXHIBIT 10.16 | tm2035121d10_ex10-16.htm | EX-10.16 | 333790 |
16 | EXHIBIT 21.1 | tm2035121d10_ex21-1.htm | EX-21.1 | 4122 |
17 | EXHIBIT 23.1 | tm2035121d10_ex23-1.htm | EX-23.1 | 2700 |
18 | GRAPHIC | image_001.jpg | GRAPHIC | 1561 |
19 | GRAPHIC | image_002.jpg | GRAPHIC | 1457 |
20 | GRAPHIC | image_003.jpg | GRAPHIC | 1331 |
21 | GRAPHIC | lg_vaccitech-4c.jpg | GRAPHIC | 658481 |
22 | GRAPHIC | tm2035121d1-bc_changebw.jpg | GRAPHIC | 229579 |
23 | GRAPHIC | tm2035121d1-bc_genotype4c.jpg | GRAPHIC | 87115 |
24 | GRAPHIC | tm2035121d1-bc_korea4clr.jpg | GRAPHIC | 76311 |
25 | GRAPHIC | tm2035121d1-lc_elisabwlr.jpg | GRAPHIC | 332497 |
26 | GRAPHIC | tm2035121d1-lc_inbredbwlr.jpg | GRAPHIC | 108629 |
27 | GRAPHIC | tm2035121d1-lc_optimis4clr.jpg | GRAPHIC | 345487 |
28 | GRAPHIC | tm2035121d1-lc_responsbwlr.jpg | GRAPHIC | 499346 |
29 | GRAPHIC | tm2035121d1-lc_virolog4clr.jpg | GRAPHIC | 147614 |
30 | GRAPHIC | tm2035121d1-pg_effect4clr.jpg | GRAPHIC | 832571 |
31 | GRAPHIC | tm2035121d1-pg_hepatitis4c.jpg | GRAPHIC | 1669735 |
32 | GRAPHIC | tm2035121d1-pg_humor4clr.jpg | GRAPHIC | 164720 |
33 | GRAPHIC | tm2035121d1-pg_inbred4clr.jpg | GRAPHIC | 2084418 |
34 | GRAPHIC | tm2035121d1-pg_inna4c.jpg | GRAPHIC | 1036261 |
35 | GRAPHIC | tm2035121d1-pg_murine4clr.jpg | GRAPHIC | 1836493 |
36 | GRAPHIC | tm2035121d1-pg_progre4clr.jpg | GRAPHIC | 1728170 |
37 | GRAPHIC | tm2035121d1-pg_survival4clr.jpg | GRAPHIC | 40500 |
38 | GRAPHIC | tm2035121d1-tbl_mage4c.jpg | GRAPHIC | 61808 |
39 | GRAPHIC | tm2035121d10_ex10-3img001.jpg | GRAPHIC | 3963 |
40 | GRAPHIC | tm2035121d10_ex10-3img002.jpg | GRAPHIC | 11424 |
41 | GRAPHIC | tm2035121d10_ex10-5img001.jpg | GRAPHIC | 3577 |
42 | GRAPHIC | tm2035121d10_ex10-5img02.jpg | GRAPHIC | 10520 |
43 | GRAPHIC | tm2035121d10_ex3-1spl1img001.jpg | GRAPHIC | 2876 |
44 | GRAPHIC | tm2035121d10_ex3-2image01.jpg | GRAPHIC | 3110 |
45 | GRAPHIC | tm2035121d10_ex3-2image02.jpg | GRAPHIC | 3970 |
46 | GRAPHIC | tm2035121d10_ex3-2image03.jpg | GRAPHIC | 3976 |
47 | GRAPHIC | tm2035121d10_ex3-2image05.jpg | GRAPHIC | 3976 |
48 | GRAPHIC | tm2035121d10_ex3-2img001.jpg | GRAPHIC | 2752 |
49 | GRAPHIC | tm2035121d10_ex3-2sp01img03.jpg | GRAPHIC | 2797 |
50 | GRAPHIC | tm2035121d10_ex3-2sp2img01.jpg | GRAPHIC | 2569 |
51 | GRAPHIC | tm2035121d10_ex3-2sp2img02.jpg | GRAPHIC | 2569 |
52 | GRAPHIC | tm2035121d10_ex3-2sp2img03.jpg | GRAPHIC | 2569 |
53 | GRAPHIC | tm2035121d10_ex3-2sp2img04.jpg | GRAPHIC | 2569 |
54 | GRAPHIC | tm2035121d10_ex3-2sp2img05.jpg | GRAPHIC | 2569 |
55 | GRAPHIC | tm2035121d10_ex3-2sp2img06.jpg | GRAPHIC | 2569 |
56 | GRAPHIC | tm2035121d10_ex3-2sp2img07.jpg | GRAPHIC | 2569 |
57 | GRAPHIC | tm2035121d10_ex3-2sp2img08.jpg | GRAPHIC | 2569 |
58 | GRAPHIC | tm2035121d10_ex3-2sp2img09.jpg | GRAPHIC | 2569 |
59 | GRAPHIC | tm2035121d10_ex3-2sp2img10.jpg | GRAPHIC | 2569 |
60 | GRAPHIC | tm2035121d10_ex3-2sp2img11.jpg | GRAPHIC | 2569 |
61 | GRAPHIC | tm2035121d10_ex3-2sp2img12.jpg | GRAPHIC | 2569 |
62 | GRAPHIC | tm2035121d10_ex3-2sp2img13.jpg | GRAPHIC | 2569 |
63 | GRAPHIC | tm2035121d10_ex3-2sp2img14.jpg | GRAPHIC | 2569 |
64 | GRAPHIC | tm2035121d1_fc-cd44c.jpg | GRAPHIC | 185329 |
65 | GRAPHIC | tm2035121d1_lc-agespc4clr.jpg | GRAPHIC | 912093 |
66 | GRAPHIC | tm2035121d1_lc-humo4clr.jpg | GRAPHIC | 100735 |
67 | GRAPHIC | tm2035121d1_lc-meantum4clr.jpg | GRAPHIC | 29593 |
68 | GRAPHIC | tm2035121d2-pg_immuno4c.jpg | GRAPHIC | 98361 |
69 | GRAPHIC | tm2035121d7-bc_tcell4c.jpg | GRAPHIC | 58697 |
70 | GRAPHIC | tm2035121d7-tbl_group4c.jpg | GRAPHIC | 178824 |
71 | GRAPHIC | tm2035121d7-tbl_health4c.jpg | GRAPHIC | 185449 |
72 | GRAPHIC | tm2035121d7-tbl_pipe4c.jpg | GRAPHIC | 176739 |
73 | GRAPHIC | tm2035121d8_ex10-16img001.jpg | GRAPHIC | 4525 |
74 | GRAPHIC | tm2035121d8_ex10-16img002.jpg | GRAPHIC | 138299 |
75 | GRAPHIC | tm2035121d8_ex10-1img001.jpg | GRAPHIC | 1929 |
Complete submission text file | 0001104659-21-048698.txt | 26562181 |
IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-255158 | Film No.: 21817921
SIC: 2834 Pharmaceutical Preparations